Ceesay Abraham
- SEC CIK
- 0001722140
In the past year, 12 open-market sale filings worth $6.07M and no purchases.
Current role at each company
- RAPP Rapport Therapeutics, Inc.Chief Executive Officeras of Sep 24, 2026
- CRL Charles River Laboratories International, Inc.Directoras of May 11, 2026
- PCRX Pacira BioSciences, Inc.Directoras of Sep 8, 2025
- CERE Cerevel Therapeutics Holdings, Inc.Presidentas of Feb 8, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $6.07M
- 12 filings
- Net
- −$6.07M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Ceesay Abraham as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
RAPP Rapport Therapeutics, Inc.
Chief Executive Officer19 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 19, 2025 (view filing) | Sep 17 | 2 days | Ceesay AbrahamChief Executive Officer | SSale | −40.8K | $26.32 | −$1.07M | −6.5%585.4K after | 2 lots10b5-1 |
| Sep 19, 2025 (view filing) | Sep 17 | 2 days | Ceesay AbrahamChief Executive Officer | SSale | −35.6K | $26.31 | −$936.4K | −43.5%46.1K after | 2 lots10b5-1 |
| Oct 16, 2025 (view filing) | Oct 15 | 1 day | Ceesay AbrahamChief Executive Officer | SSale | −5.83K | $25.81 | −$150.5K | −1.0%579.6K after | 2 lots10b5-1 |
| Oct 16, 2025 (view filing) | Oct 15 | 1 day | Ceesay AbrahamChief Executive Officer | SSale | −5.08K | $25.81 | −$131.2K | −11.0%41.1K after | 2 lots10b5-1 |
| Nov 18, 2025 (view filing) | Nov 17 | 1 day | Ceesay AbrahamChief Executive Officer | SSale | −5.83K | $25.19 | −$146.9K | −1.0%573.7K after | 2 lots10b5-1 |
| Nov 18, 2025 (view filing) | Nov 17 | 1 day | Ceesay AbrahamChief Executive Officer | SSale | −5.08K | $25.21 | −$128.1K | −12.4%36.0K after | 2 lots10b5-1 |
| Dec 18, 2025 (view filing) | Dec 17 | 1 day | Ceesay AbrahamChief Executive Officer | SSale | −5.83K | $29.64 | −$172.9K | −1.0%567.9K after | 3 lots10b5-1 |
| Dec 18, 2025 (view filing) | Dec 17 | 1 day | Ceesay AbrahamChief Executive Officer | SSale | −5.08K | $29.63 | −$150.6K | −14.1%30.9K after | 3 lots10b5-1 |
| Jan 22, 2026 (view filing) | Jan 20 | 2 days | Ceesay AbrahamChief Executive Officer | SSale | −5.83K | $26.12 | −$152.4K | −1.0%562.1K after | 10b5-1 |
| Jan 22, 2026 (view filing) | Jan 20 | 2 days | Ceesay AbrahamChief Executive Officer | SSale | −5.08K | $26.11 | −$132.7K | −16.5%25.8K after | 10b5-1 |
PCRX Pacira BioSciences, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2025 (view filing) | Sep 4 | 4 days | Ceesay AbrahamDirector | SSale | −2.35K | $27.19 | −$64.0K | −20.7%9.04K after | 10b5-1 |
CERE Cerevel Therapeutics Holdings, Inc.
President4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 9, 2022 (view filing) | Aug 5-8 | 4 days | Ceesay AbrahamPresident | SSale | −57.6K | $34.54 | −$1.99M | −100.0%0 after | 3 lots |
| Aug 17, 2022 (view filing) | Aug 15 | 2 days | Ceesay AbrahamPresident | SSale | −9.61K | $34.12 | −$327.8K | −100.0%0 after | |
| Aug 24, 2022 (view filing) | Aug 22 | 2 days | Ceesay AbrahamPresident | SSale | −9.61K | $32.50 | −$312.2K | −100.0%0 after | |
| Sep 12, 2022 (view filing) | Sep 8 | 4 days | Ceesay AbrahamPresident | SSale | −19.2K | $32.50 | −$624.3K | −100.0%0 after |